Cargando…

The potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the German city of Bremen: a simulation study

BACKGROUND: According to the German guidelines, people with severe alcohol use disorders (AUDs) should receive withdrawal treatment. Compared to somatic withdrawal treatment (SWT), extended duration and psychosocial elements of so-called “qualified withdrawal treatment” (QWT) aim to reduce relapse r...

Descripción completa

Detalles Bibliográficos
Autores principales: Manthey, Jakob, Lindemann, Christina, Kraus, Ludwig, Reimer, Jens, Verthein, Uwe, Schulte, Bernd, Rehm, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941395/
https://www.ncbi.nlm.nih.gov/pubmed/31898529
http://dx.doi.org/10.1186/s13011-019-0249-7
_version_ 1783484546825584640
author Manthey, Jakob
Lindemann, Christina
Kraus, Ludwig
Reimer, Jens
Verthein, Uwe
Schulte, Bernd
Rehm, Jürgen
author_facet Manthey, Jakob
Lindemann, Christina
Kraus, Ludwig
Reimer, Jens
Verthein, Uwe
Schulte, Bernd
Rehm, Jürgen
author_sort Manthey, Jakob
collection PubMed
description BACKGROUND: According to the German guidelines, people with severe alcohol use disorders (AUDs) should receive withdrawal treatment. Compared to somatic withdrawal treatment (SWT), extended duration and psychosocial elements of so-called “qualified withdrawal treatment” (QWT) aim to reduce relapse rates. Despite promising results of prospective studies on QWT, only few German inpatients seeking withdrawal treatment receive QWT. We estimated the potential effects on mortality and morbidity for higher proportions of treatment-seeking patients receiving QWT rather than SWT in the German city of Bremen. METHODS: In 2016 and 2017, 2051 inpatients were admitted to two specialised hospitals for withdrawal treatment. The potential beneficial effects of QWT over SWT were estimated by simulating treatment outcomes taken from two prospective studies. Outcomes comprised number and length of all-cause hospitalisations within 5 years, as well as abstinence and all-cause mortality rates within 28 months. Outcomes were estimated for actual and increased rates of QWT (25, 50%) among inpatients seeking alcohol treatment. RESULTS: In the selected hospitals, 170 patients (8%) received QWT. If 25% of AUD inpatients were to receive QWT, benefits in abstinence rates (+ 18%), the total number of hospitalisations (− 9%) and hospital days (− 10%) could be expected. If 50% of AUD inpatients were to receive QWT, benefits in abstinence rates (+ 45%), the total number of hospitalisations (− 23%) and hospital days (− 26%) were more pronounced, in addition to reductions in mortality (− 20%). CONCLUSION: Increasing the proportion of people with severe AUD enrolled in extended withdrawal treatment programs (such as QWT) may contribute to reduce overall alcohol-attributable burden of disease. Randomised controlled trials or other prospective studies controlling for confounding factors are needed to determine the potential at the population level.
format Online
Article
Text
id pubmed-6941395
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69413952020-01-06 The potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the German city of Bremen: a simulation study Manthey, Jakob Lindemann, Christina Kraus, Ludwig Reimer, Jens Verthein, Uwe Schulte, Bernd Rehm, Jürgen Subst Abuse Treat Prev Policy Research BACKGROUND: According to the German guidelines, people with severe alcohol use disorders (AUDs) should receive withdrawal treatment. Compared to somatic withdrawal treatment (SWT), extended duration and psychosocial elements of so-called “qualified withdrawal treatment” (QWT) aim to reduce relapse rates. Despite promising results of prospective studies on QWT, only few German inpatients seeking withdrawal treatment receive QWT. We estimated the potential effects on mortality and morbidity for higher proportions of treatment-seeking patients receiving QWT rather than SWT in the German city of Bremen. METHODS: In 2016 and 2017, 2051 inpatients were admitted to two specialised hospitals for withdrawal treatment. The potential beneficial effects of QWT over SWT were estimated by simulating treatment outcomes taken from two prospective studies. Outcomes comprised number and length of all-cause hospitalisations within 5 years, as well as abstinence and all-cause mortality rates within 28 months. Outcomes were estimated for actual and increased rates of QWT (25, 50%) among inpatients seeking alcohol treatment. RESULTS: In the selected hospitals, 170 patients (8%) received QWT. If 25% of AUD inpatients were to receive QWT, benefits in abstinence rates (+ 18%), the total number of hospitalisations (− 9%) and hospital days (− 10%) could be expected. If 50% of AUD inpatients were to receive QWT, benefits in abstinence rates (+ 45%), the total number of hospitalisations (− 23%) and hospital days (− 26%) were more pronounced, in addition to reductions in mortality (− 20%). CONCLUSION: Increasing the proportion of people with severe AUD enrolled in extended withdrawal treatment programs (such as QWT) may contribute to reduce overall alcohol-attributable burden of disease. Randomised controlled trials or other prospective studies controlling for confounding factors are needed to determine the potential at the population level. BioMed Central 2020-01-02 /pmc/articles/PMC6941395/ /pubmed/31898529 http://dx.doi.org/10.1186/s13011-019-0249-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Manthey, Jakob
Lindemann, Christina
Kraus, Ludwig
Reimer, Jens
Verthein, Uwe
Schulte, Bernd
Rehm, Jürgen
The potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the German city of Bremen: a simulation study
title The potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the German city of Bremen: a simulation study
title_full The potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the German city of Bremen: a simulation study
title_fullStr The potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the German city of Bremen: a simulation study
title_full_unstemmed The potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the German city of Bremen: a simulation study
title_short The potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the German city of Bremen: a simulation study
title_sort potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the german city of bremen: a simulation study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941395/
https://www.ncbi.nlm.nih.gov/pubmed/31898529
http://dx.doi.org/10.1186/s13011-019-0249-7
work_keys_str_mv AT mantheyjakob thepotentialeffectsofanextendedalcoholwithdrawaltreatmentprogrammeonmorbidityandmortalityamonginpatientsinthegermancityofbremenasimulationstudy
AT lindemannchristina thepotentialeffectsofanextendedalcoholwithdrawaltreatmentprogrammeonmorbidityandmortalityamonginpatientsinthegermancityofbremenasimulationstudy
AT krausludwig thepotentialeffectsofanextendedalcoholwithdrawaltreatmentprogrammeonmorbidityandmortalityamonginpatientsinthegermancityofbremenasimulationstudy
AT reimerjens thepotentialeffectsofanextendedalcoholwithdrawaltreatmentprogrammeonmorbidityandmortalityamonginpatientsinthegermancityofbremenasimulationstudy
AT vertheinuwe thepotentialeffectsofanextendedalcoholwithdrawaltreatmentprogrammeonmorbidityandmortalityamonginpatientsinthegermancityofbremenasimulationstudy
AT schultebernd thepotentialeffectsofanextendedalcoholwithdrawaltreatmentprogrammeonmorbidityandmortalityamonginpatientsinthegermancityofbremenasimulationstudy
AT rehmjurgen thepotentialeffectsofanextendedalcoholwithdrawaltreatmentprogrammeonmorbidityandmortalityamonginpatientsinthegermancityofbremenasimulationstudy
AT mantheyjakob potentialeffectsofanextendedalcoholwithdrawaltreatmentprogrammeonmorbidityandmortalityamonginpatientsinthegermancityofbremenasimulationstudy
AT lindemannchristina potentialeffectsofanextendedalcoholwithdrawaltreatmentprogrammeonmorbidityandmortalityamonginpatientsinthegermancityofbremenasimulationstudy
AT krausludwig potentialeffectsofanextendedalcoholwithdrawaltreatmentprogrammeonmorbidityandmortalityamonginpatientsinthegermancityofbremenasimulationstudy
AT reimerjens potentialeffectsofanextendedalcoholwithdrawaltreatmentprogrammeonmorbidityandmortalityamonginpatientsinthegermancityofbremenasimulationstudy
AT vertheinuwe potentialeffectsofanextendedalcoholwithdrawaltreatmentprogrammeonmorbidityandmortalityamonginpatientsinthegermancityofbremenasimulationstudy
AT schultebernd potentialeffectsofanextendedalcoholwithdrawaltreatmentprogrammeonmorbidityandmortalityamonginpatientsinthegermancityofbremenasimulationstudy
AT rehmjurgen potentialeffectsofanextendedalcoholwithdrawaltreatmentprogrammeonmorbidityandmortalityamonginpatientsinthegermancityofbremenasimulationstudy